Function of the c-Myc antagonist mad1 during a molecular switch from proliferation to differentiation

被引:65
作者
Cultraro, CM
Bino, T
Segal, S
机构
[1] NCI,NAVY MED ONCOL BRANCH,NIH,BETHESDA,MD 20889
[2] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20889
关键词
D O I
10.1128/MCB.17.5.2353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mad-Max heterodimers have been shown to antagonize Myc transforming activity by a mechanism requiring multiple protein-protein and protein-DNA interactions. However, the mechanism by which Mad functions in differentiation is unknown. Here, we present evidence that Mad functions by an active repression mechanism to antagonize the growth-promoting function(s) of Myc and bring about a transition from cellular proliferation to differentiation. We demonstrate that exogenously expressed c-Myc blocks inducer-mediated differentiation of murine erythroleukemia cells without disrupting the induction of endogenous Mad; rather, high levels of c-Myc prevent a heterocomplex switch from growth-promoting Myc-Max to growth-inhibitory Mad-Max. Cotransfection of a constitutive c-myc with a zinc-inducible madl results in clones expressing both genes, whereby a switch from proliferation to differentiation can be modulated. Whereas cells grown in N'N'-hexamethylene bisacetamide in the absence of zinc fail to differentiate, addition of zinc up-regulates Mad expression by severalfold and differentiation proceeds normally. Coimmunoprecipitation analysis reveals that Mad-Max complexes are in excess of Myc-Max in these cotransfectants. Moreover, we show that the Sin-binding, basic region, and leucine zipper motifs are required for Mad to function during a molecular switch from proliferation to differentiation.
引用
收藏
页码:2353 / 2359
页数:7
相关论文
共 50 条
[31]   c-Myc controls proliferation versus differentiation in human pancreatic endocrine cells [J].
Demeterco, C ;
Itkin-Ansari, P ;
Tyrberg, B ;
Ford, LP ;
Jarvis, RA ;
Levine, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) :3475-3485
[32]   The MYC-antagonist MAD1 and p27KIP1 cooperate to inhibit cyclin E:Cdk2 activity and promote differentiation of granulocytes. [J].
McArthur, GA ;
Foley, KP ;
Ramos, LS ;
Eisenman, RN .
BLOOD, 1998, 92 (10) :672A-672A
[33]   Regulation and function of the MYC-antagonist Mad-1 in hematopoietic cells. [J].
McArthur, GA ;
Foley, KP ;
Queva, C ;
Pulverer, B ;
Eisenman, RN .
EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) :486-486
[34]   Isolation and comparative expression analysis of the Myc-regulatory proteins Mad1, Mad3, and Mnt during Xenopus development [J].
Juergens, K ;
Rust, B ;
Pieler, T ;
Henningfeld, KA .
DEVELOPMENTAL DYNAMICS, 2005, 233 (04) :1554-1559
[35]   EFFECTS OF ORNITHINE DECARBOXYLASE INHIBITION ON C-MYC EXPRESSION DURING MURINE ERYTHROLEUKEMIA CELL-PROLIFERATION AND DIFFERENTIATION [J].
WATANABE, T ;
SHERMAN, M ;
SHAFMAN, T ;
IWATA, T ;
KUFE, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1986, 127 (03) :480-484
[36]   Assembly of b/HLH/z proteins c-Myc, Max, and Mad1 with cognate DNA: Importance of protein-protein and protein-DNA interactions [J].
Hu, JZ ;
Banerjee, A ;
Goss, DJ .
BIOCHEMISTRY, 2005, 44 (35) :11855-11863
[37]   Mad1 function in cell proliferation and transcriptional repression is antagonized by cyclin E/CDK2 [J].
Rottmann, S ;
Menkel, AR ;
Bouchard, C ;
Mertsching, J ;
Loidl, P ;
Kremmer, E ;
Eilers, M ;
Lüscher-Firzlaff, J ;
Lilischkis, R ;
Lüscher, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :15489-15492
[38]   Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression [J].
He, LS ;
Liu, JH ;
Collins, I ;
Sanford, S ;
O'Connell, B ;
Benham, CJ ;
Levens, D .
EMBO JOURNAL, 2000, 19 (05) :1034-1044
[39]   The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways [J].
Shen, Congxiang ;
Chen, Fang ;
Wang, Huigang ;
Li, Guanxue ;
Yu, Chaosheng ;
Wang, Xiaoqi ;
Wen, Zhong .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) :282-294
[40]   Egr-1 abrogates the block imparted by c-Myc on terminal myeloid differentiation without arresting proliferation [J].
Shafarenko, M ;
Liebermann, DA ;
Hoffman, B .
BLOOD, 2002, 100 (11) :208B-208B